Archangium gephyra KYC5002 produces tubulysins during the death phase. In this study, we aimed to determine whether dead cells produce tubulysins. Cells were cultured for three days until the verge of the death phase, disrupted via ultrasonication, incubated for 2 h, and examined for tubulysin production.
Non-disrupted cells produced 0.14 mg/L of tubulysin A and 0.11 mg/L of tubulysin B. Notably, tubulysin A production was increased by 4.4-fold to 0.62 mg/L and that of tubulysin B was increased by 6.7-fold to 0.74 mg/L in the disrupted cells. The same increase in tubulysin production was observed when the cells were killed by adding hydrogen peroxide. However, when the enzymes were inactivated via heat treatment of the cultures at 65 °C for 30 min, no significant increase in tubulysin production due to cell death was observed. Reverse transcription-quantitative polymerase chain reaction analysis of tubB mRNA revealed that the expression levels of tubulysin biosynthetic enzyme genes increased during the death phase compared to those during the vegetative growth phase. Our findings suggest that A. gephyra produces biosynthetic enzymes and subsequently uses them for tubulysin production in the cell death phase or during cell lysis by predators.
Hepatitis C virus (HCV) life cycle is highly dependent on cellular
proteins for viral propagation. In order to identify the
cellular factors involved in HCV propagation, we previously
performed a protein microarray assay using the HCV nonstructural
5A (NS5A) protein as a probe. Of ~9,000 human
cellular proteins immobilized in a microarray, adenosylhomocysteinase
like 1 (AHCYL1) was among 90 proteins identified
as NS5A interactors. Of these candidates, AHCYL1 was
selected for further study. In the present study, we verified
the physical interaction between NS5A and AHCYL1 by both
in vitro pulldown and coimmunoprecipitation assays. Furthermore,
HCV NS5A interacted with endogenous AHCYL1 in
Jc1-infected cells. Both NS5A and AHCYL1 were colocalized
in the cytoplasmic region in HCV-replicating cells. siRNAmediated
knockdown of AHCYL1 abrogated HCV propagation.
Exogenous expression of the siRNA-resistant AHCYL1
mutant, but not of the wild-type AHCYL1, restored HCV protein
expression levels, indicating that AHCYL1 was required
specifically for HCV propagation. Importantly, AHCYL1 was
involved in the HCV internal ribosome entry site-mediated
translation step of the HCV life cycle. Finally, we demonstrated
that the proteasomal degradation pathway of AHCYL1 was
modulated by persistent HCV infection. Collectively, these
data suggest that HCV may modulate the AHCYL1 protein
to promote viral propagation.
Citations
Citations to this article as recorded by
Amuvatinib Blocks SARS-CoV-2 Infection at the Entry Step of the Viral Life Cycle Trang T. X. Huynh, Thuy X. Pham, Gun-Hee Lee, Jae-Bong Lee, Sung-Geun Lee, Dongseob Tark, Yun-Sook Lim, Soon B. Hwang, Donna M. Neumann Microbiology Spectrum.2023;[Epub] CrossRef
Inhibition of KIF20A suppresses the replication of influenza A virus by inhibiting viral entry Hoyeon Jeon, Younghyun Lim, In-Gu Lee, Dong-In Kim, Keun Pil Kim, So-Hee Hong, Jeongkyu Kim, Youn-Sang Jung, Young-Jin Seo Journal of Microbiology.2022; 60(11): 1113. CrossRef
Asunaprevir, a Potent Hepatitis C Virus Protease Inhibitor, Blocks SARS-CoV-2 Propagation Yun-Sook Lim, Lap P. Nguyen, Gun-Hee Lee, Sung-Geun Lee, Kwang-Soo Lyoo, Bumseok Kim, Soon B. Hwang Molecules and Cells.2021; 44(9): 688. CrossRef